Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
Follow dosage below or use as directed by a physician. do not take more than 6 doses in any 24-hour period. Age (yr) Dose (mL) adults and children 12 years and over 10 mL (2 teaspoonfuls) every 4 hours children 6 years to under 12 years 5 mL (1 teaspoonful) every 4 hours children 2 years to under 6 years 2.5 mL (1/2 teaspoonful) every 4 hours children under 2 years ask a doctor
Guaifenesin 200 mg
Dextromethorphan Hydrobromide 20 mg
Expectorant
Cough Suppressant
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Follow dosage below or use as directed by a physician.
Age (yr) | Dose (mL) |
adults and children 12 years and over | 10 mL (2 teaspoonfuls) every 4 hours |
children 6 years to under 12 years | 5 mL (1 teaspoonful) every 4 hours |
children 2 years to under 6 years | 2.5 mL (1/2 teaspoonful) every 4 hours |
children under 2 years | ask a doctor |
citric acid, FD&C Red No. 40, flavoring, glycerin, menthol, purified water, sodium benzoate, sodium citrate, sodium saccharin, and sucrose.
Call 1-800-845-8210
Professional Note: Guaifenesin has been shown to produce a color interference with certain clinical laboratory determinations of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).
Distributed by:
American Health Packaging
Columbus, OH 43217
R0324
Case NDC 60687-828-56/Cup NDC 60687-828-42
GUAIFENESIN and
DEXTROMETHORPHAN
SYRUP
Expectorant/Cough Suppressant
200 mg/20 mg per 10 mL
Non-Narcotic, Alcohol Free
Cherry Flavor
Usual Dosage: See attached Drug Facts.
Store at 20° to 25°C (68° to 77°F) [See USP]
Protect from light.
FOR INSTITUTIONAL USE ONLY
T0638C100324 R03/24

NDC 60687- 828-42
Guaifenesin and
Dextromethorphan Syrup
Expectorant/cough Suppressant
200 mg/20 mg per 10 mL
Sodium Content: 8 mg/10 mL
Delivers 10 mL
Protect from light
See package Drug Facts insert for full
prescribing information and storage
For Institutional Use Only.
American Health Packaging
Columbus, OH 43217
F0638C100224
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 996520 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution | PSN | 1 |
| 996520 | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 1 |
| 996520 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 1 |
| 996520 | dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution | SY | 1 |
| 996520 | dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-828-42 | Guaifenesin DM | 10 mL in 1 CUP, UNIT-DOSE | SYRUP | 10 | 1 | |
| 60687-828-48 | Guaifenesin DM | 10 in 1 TRAY | SYRUP | 10 | 1 | |
| 60687-828-56 | Guaifenesin DM | 10 in 1 CASE | SYRUP | 10 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-828-42 | ML - Milliliter | 60687-828 | 6d4e5ec6-2f1e-454e-b08f-9e0c798fe8e0 | 1 | 2024-08-12 |
| 60687-828-56 | ML - Milliliter | 60687-828 | d2313ab3-6e3c-49be-b3e5-8e3d61f4dcdc | 1 | 2024-08-12 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60687-828 | 60687-828-42, 60687-828-48, 60687-828-56 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| MENTHOL, UNSPECIFIED FORM | L7T10EIP3A | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE, UNSPECIFIED FORM | 1Q73Q2JULR | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SUCROSE | C151H8M554 | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
| DEXTROMETHORPHAN | 7355X3ROTS | ACTIR |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guaifenesin DM | GUAIFENESIN AND DEXTROMETHORPHAN | American Health Packaging | 8632a655-7f5b-450f-95fa-62478a174e9c | 2024-08-04 | Warnings | 60687-828-48 60687-828-56 60687-828-42 60687-828 60687082856 60687082848 60687082842 1d74f48d-1aa4-b779-e063-6394a90af176 8632a655-7f5b-450f-95fa-62478a174e9c |
Adverse event summaries are temporarily unavailable. Other product information remains available.